Unnamed: 0,title,date,stock,sentiment
26740.0,72 Biggest Movers From Friday,2020-06-01 04:53:00-04:00,ADMA,neutral
26741.0,50 Stocks Moving In Friday's Mid-Day Session,2020-05-29 12:15:00-04:00,ADMA,neutral
26742.0,ADMA Biologics Shares Ticking Higher As Traders Circulate' 60 Minutes' Description Of Sunday Report Titled 'The Promise Of Plasma',2020-05-29 09:50:00-04:00,ADMA,positive
26743.0,"ADMA Biologics shares are trading higher after the company announced it has commenced the collection of COVID-19 coronavirus plasma from recovered patients, which can be used to produce an immune globulin.",2020-05-21 07:31:00-04:00,ADMA,positive
26744.0,28 Stocks Moving in Thursday's Pre-Market Session,2020-05-21 07:17:00-04:00,ADMA,neutral
26745.0,ADMA Biologics Commences Collection Of COVID-19 Coronavirus Plasma From Recovered Patients,2020-05-21 07:04:00-04:00,ADMA,neutral
26746.0,84 Biggest Movers From Yesterday,2020-05-08 05:34:00-04:00,ADMA,neutral
26747.0,68 Stocks Moving In Thursday's Mid-Day Session,2020-05-07 12:42:00-04:00,ADMA,neutral
26748.0,"Oppenheimer Maintains Outperform on ADMA Biologics, Lowers Price Target to $7",2020-05-07 10:13:00-04:00,ADMA,negative
26749.0,ADMA Biologics Outlines Recent Corporate Achievements Related To Its Supply Chain,2020-05-07 08:21:00-04:00,ADMA,neutral
26750.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,ADMA,negative
26751.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-07 07:32:00-04:00,ADMA,neutral
26752.0,"ADMA Biologics Q1 EPS $(0.260) Misses $(0.120) Estimate, Sales $10.200M Miss $10.880M Estimate",2020-05-06 16:38:00-04:00,ADMA,negative
26753.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,ADMA,positive
26754.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,ADMA,neutral
26755.0,74 Biggest Movers From Friday,2020-04-06 04:46:00-04:00,ADMA,neutral
26756.0,FDA Says Some Limited Data To Suggest Convalescent Plasma & Hyperimmune Globulin May Have Benefit In Coronavirus,2020-04-03 12:51:00-04:00,ADMA,positive
26757.0,"FDA Is Facilitating Access To Convalescent Plasma For Treating Coronavirus Using Multiple Pathways, Plans To Provide Convalescent Plasma To Patients In Need Who May Not Have Access To Institutions With Clinical Trials In Place",2020-04-03 12:44:00-04:00,ADMA,neutral
26758.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 09:22:00-04:00,ADMA,positive
26759.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-25 07:35:00-04:00,ADMA,neutral
26760.0,111 Biggest Movers From Yesterday,2020-03-24 04:18:00-04:00,ADMA,neutral
26761.0,71 Stocks Moving In Monday's Mid-Day Session,2020-03-23 12:31:00-04:00,ADMA,neutral
26762.0,36 Stocks Moving in Monday's Pre-Market Session,2020-03-23 07:38:00-04:00,ADMA,neutral
26763.0,Shares of several healthcare companies are trading higher as the market rebounds from coronavirus-related selloffs.,2020-03-20 09:43:00-04:00,ADMA,positive
26764.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,ADMA,positive
26765.0,Shares of several companies in the healthcare space are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 10:18:00-04:00,ADMA,negative
26766.0,"H.C. Wainwright Maintains Buy on ADMA Biologics, Lowers Price Target to $12",2020-03-16 07:24:00-04:00,ADMA,negative
26767.0,"ADMA Biologics Q4 EPS $(0.18), Inline, Sales $12M Beat $10.23M Estimate",2020-03-12 16:27:00-04:00,ADMA,neutral
26768.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,ADMA,negative
26769.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,ADMA,negative
26770.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,ADMA,positive
26771.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,ADMA,negative
26772.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,ADMA,neutral
26773.0,"The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues",2020-03-08 16:14:00-04:00,ADMA,negative
26774.0,92 Biggest Movers From Yesterday,2020-03-05 04:41:00-05:00,ADMA,neutral
26775.0,60 Stocks Moving In Wednesday's Mid-Day Session,2020-03-04 12:11:00-05:00,ADMA,neutral
26776.0,Shares of several healthcare-related companies are trading higher after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:16:00-05:00,ADMA,positive
26777.0,ADMA Biologics shares are trading higher after the company received a notice of allowance for a patent application for its portfolio encompassing immunoglobulin plasma pool compositions used in the manufacturing of ASCENIV.,2020-03-03 08:29:00-05:00,ADMA,positive
26778.0,40 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-03 08:10:00-05:00,ADMA,neutral
26779.0,ADMA Biologics Received A Noticed Of Allowance From The U.S. Patent and Trademark Office For A Patent Application Related To Is Intellectual Property Portfolio,2020-03-03 07:11:00-05:00,ADMA,positive
26780.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,ADMA,negative
26781.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,ADMA,negative
26782.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-19 08:10:00-05:00,ADMA,neutral
26783.0,35 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-02-18 08:25:00-05:00,ADMA,neutral
26784.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-12 07:35:00-05:00,ADMA,neutral
26785.0,12 Biotechnology Stocks Moving In Wednesday's Pre-Market Session,2020-02-12 07:33:00-05:00,ADMA,neutral
26786.0,95 Biggest Movers From Friday,2020-02-10 05:20:00-05:00,ADMA,neutral
26787.0,ADMA Biologics shares are trading lower after the company priced its upsized 23.5 million shares common stock offering at $3.5 per share.,2020-02-07 10:02:00-05:00,ADMA,positive
26788.0,16 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-02-07 07:39:00-05:00,ADMA,neutral
26789.0,10 Biotechnology Stocks Moving In Friday's Pre-Market Session,2020-02-07 07:35:00-05:00,ADMA,neutral
26790.0,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",2020-02-07 07:32:00-05:00,ADMA,negative
26791.0,46 Stocks Moving in Friday's Pre-Market Session,2020-02-07 07:25:00-05:00,ADMA,neutral
26792.0,ADMA Biologics Prices Upsized 23.5M Share Public Offering of Common Stock @$3.50/Share,2020-02-07 05:29:00-05:00,ADMA,positive
26793.0,29 Stocks Moving In Thursday's After-Hours Session,2020-02-06 17:23:00-05:00,ADMA,neutral
26794.0,ADMA shares trading lower following $75 million common stock offering.,2020-02-06 16:55:00-05:00,ADMA,neutral
26795.0,ADMA Biologics Announces Proposed $75 Million Public Offering of Common Stock,2020-02-06 16:35:00-05:00,ADMA,neutral
26796.0,ADMA Biologics Reports $75M Offering,2020-02-06 16:09:00-05:00,ADMA,neutral
26797.0,64 Biggest Movers From Yesterday,2020-01-10 04:58:00-05:00,ADMA,neutral
26798.0,Mid-Afternoon Market Update: Bed Bath & Beyond Tumbles Following Q3 Miss; Applied Genetic Technologies Shares Jump,2020-01-09 15:11:00-05:00,ADMA,positive
26799.0,Mid-Day Market Update: Dow Surges Over 200 Points; Tufin Software Technologies Shares Plunge,2020-01-09 12:14:00-05:00,ADMA,positive
26800.0,32 Stocks Moving In Thursday's Mid-Day Session,2020-01-09 12:08:00-05:00,ADMA,neutral
26801.0,ADMA Biologics Sees Q4 Sales $11.9M vs $8.64M Estimate; FY19 Sales $29.2M vs $25.4M Est.,2020-01-09 07:02:00-05:00,ADMA,neutral
26802.0,ADMA Biologics Enters Into Manufacturing And Supply Agreement To Produce And Sell Plasma-Derived Intermediate Fractions; Agreement Expected To Add $5M-$10M In Annual Revenues For 2020 And 2021,2020-01-07 07:07:00-05:00,ADMA,positive
26803.0,ADMA Biologics Added To NASDAQ Biotechnology Index,2019-12-17 07:12:00-05:00,ADMA,neutral
26804.0,"ADMA Biologics Q3 EPS $(0.19) Up From $(0.33) YoY, Sales $7.2M Up From $4.23M YoY",2019-11-06 17:35:00-05:00,ADMA,neutral
26805.0,ADMA Biologics Announces the First Commercial Sales of ASCENIV,2019-10-21 07:52:00-04:00,ADMA,neutral
26806.0,ADMA Biologics Announces Data Presented at IDWeek 2019,2019-10-07 07:16:00-04:00,ADMA,neutral
26807.0,21 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-09-26 08:10:00-04:00,ADMA,neutral
26808.0,ADMA Biomanufacturing Says Entered Into Amendment To Transition Services Agreement With Biotest Pharmaceuticals Corporation,2019-09-05 17:04:00-04:00,ADMA,positive
26809.0,ADMA Biologics Announces Commercial Relaunch and its First Commercial Sales of BIVIGAM,2019-08-22 07:49:00-04:00,ADMA,neutral
26810.0,50 Healthcare Stocks Moving In Thursday's After-Market Session,2019-08-08 21:56:00-04:00,ADMA,neutral
26811.0,"ADMA Biologics Q2 EPS $(0.25) Beats $(0.29) Estimate, Sales $6.561M Beat $3.34M Estimate",2019-08-08 07:11:00-04:00,ADMA,neutral
26812.0,25 Stocks Moving In Monday's Pre-Market Session,2019-08-05 07:46:00-04:00,ADMA,neutral
26813.0,29 Healthcare Stocks Moving In Friday's After-Market Session,2019-08-02 20:51:00-04:00,ADMA,neutral
26814.0,ADMA Biologics shares are trading higher after the company received FDA approval for license transfers for BIVIGAM and Nabi-HB.,2019-07-08 08:26:00-04:00,ADMA,positive
26815.0,ADMA Biologics Receives FDA Approval for License Transfers for BIVIGAM and Nabi-HB,2019-07-08 08:22:00-04:00,ADMA,positive
26816.0,31 Stocks Moving In Tuesday's Pre-Market Session,2019-06-11 08:09:00-04:00,ADMA,neutral
26817.0,55 Biggest Movers From Yesterday,2019-06-07 05:33:00-04:00,ADMA,neutral
26818.0,42 Stocks Moving In Thursday's Mid-Day Session,2019-06-06 12:36:00-04:00,ADMA,neutral
26819.0,"Benzinga's Top Upgrades, Downgrades For June 4, 2019",2019-06-04 09:10:00-04:00,ADMA,positive
26820.0,"Jefferies Initiates Coverage On ADMA Biologics with Buy Rating, Announces $8 Price Target",2019-06-04 07:17:00-04:00,ADMA,neutral
26821.0,28 Stocks Moving In Wednesday's Pre-Market Session,2019-05-22 08:29:00-04:00,ADMA,neutral
26822.0,"The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering",2019-05-17 08:03:00-04:00,ADMA,neutral
26823.0,Adma Biologics Prices 11.3M Share Offering at $4/Share,2019-05-17 07:15:00-04:00,ADMA,positive
26824.0,63 Biggest Movers From Yesterday,2019-05-17 05:05:00-04:00,ADMA,neutral
26825.0,50 Stocks Moving In Thursday's Mid-Day Session,2019-05-16 12:36:00-04:00,ADMA,neutral
26826.0,ADMA Biologics shares are trading lower after the company announced that it has commenced a $45 million public offering of its common stock.,2019-05-16 10:31:00-04:00,ADMA,neutral
26827.0,30 Stocks Moving In Thursday's Pre-Market Session,2019-05-16 08:12:00-04:00,ADMA,neutral
26828.0,"The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics",2019-05-16 07:40:00-04:00,ADMA,neutral
26829.0,"7 Stocks To Watch For May 16, 2019",2019-05-16 04:57:00-04:00,ADMA,neutral
26830.0,6 Stocks Moving In Wednesday's After-Hours Session,2019-05-15 17:02:00-04:00,ADMA,neutral
26831.0,ADMA Biologics shares are trading lower after the company proposed a $45 million common stock offering.,2019-05-15 16:48:00-04:00,ADMA,neutral
26832.0,ADMA Biologics Reports Commencement Of $45M Common Stock Offering,2019-05-15 16:36:00-04:00,ADMA,neutral
26833.0,ADMA Biologics Shares Up 5% ~45 Mins. After Resume Time,2019-05-10 08:16:00-04:00,ADMA,positive
26834.0,ADMA Biologics Shares To Resume Trade At 7:30 a.m. EDT,2019-05-10 07:06:00-04:00,ADMA,positive
26835.0,ADMA Biologics Reports FDA Approval Of Prior Approval Supplement For BIVIGAM,2019-05-10 07:00:00-04:00,ADMA,positive
26836.0,ADMA Biologics Shares Halted News Pending,2019-05-09 17:52:00-04:00,ADMA,positive
26837.0,"ADMA Biologics Inc  Q1 EPS $(0.28) Beats $(0.32) Estimate, Sales $3.5M Beat $3.22M Estimate",2019-05-08 17:22:00-04:00,ADMA,neutral
26838.0,ADMA Biologics Elects To Draw Down $27.5M In Capital From Existing Perceptive Advisors Credit Deal,2019-05-03 07:21:00-04:00,ADMA,positive
26839.0,31 Stocks Moving In Thursday's Pre-Market Session,2019-04-18 08:40:00-04:00,ADMA,neutral
26840.0,ADMA Biologics Granted US Patent For Treatment And Prevention Of Pneumococcal Infections,2019-04-17 07:09:00-04:00,ADMA,positive
26841.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts",2019-04-07 17:04:00-04:00,ADMA,neutral
26842.0,"Benzinga Pro's Top 10 Most Searched Tickers For Morning Of Wed., Apr. 3, 2019",2019-04-03 09:58:00-04:00,ADMA,positive
26843.0,"The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings",2019-04-03 08:19:00-04:00,ADMA,positive
26844.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-04-03 08:04:00-04:00,ADMA,neutral
26845.0,54 Biggest Movers From Yesterday,2019-04-03 05:42:00-04:00,ADMA,neutral
26846.0,ADMA Receives Department of Health and Human Services U.S. License,2019-04-02 19:03:00-04:00,ADMA,neutral
26847.0,Mid-Afternoon Market Update: ADMA Biologics Jumps On FDA Nod For Immunodeficiency Therapy; Evoke Pharma Shares Plummet,2019-04-02 14:38:00-04:00,ADMA,positive
26848.0,Mid-Day Market Update: Crude Oil Up Over 1%; Apyx Medical Shares Slide,2019-04-02 12:38:00-04:00,ADMA,negative
26849.0,51 Stocks Moving In Tuesday's Mid-Day Session,2019-04-02 12:27:00-04:00,ADMA,neutral
26850.0,ADMA Biologics Rips Higher On FDA Nod For Immunodeficiency Therapy,2019-04-02 10:26:00-04:00,ADMA,neutral
26851.0,Mid-Morning Market Update: Markets Edge Lower; Walgreens Misses Q2 Views,2019-04-02 10:12:00-04:00,ADMA,negative
26852.0,ADMA Biologics shares are trading higher after the company announced the FDA approved its ASCENIV.,2019-04-02 09:26:00-04:00,ADMA,positive
26853.0,32 Stocks Moving In Tuesday's Pre-Market Session,2019-04-02 08:20:00-04:00,ADMA,neutral
26854.0,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",2019-04-02 07:30:00-04:00,ADMA,neutral
26855.0,"ADMA Biologics Shares Resume Trade, Up 42.5%",2019-04-02 07:10:00-04:00,ADMA,positive
26856.0,ADMA Biologics Inc Com Shares To Resume Trade At 7:10 a.m. EDT,2019-04-02 06:57:00-04:00,ADMA,positive
26857.0,ADMA Biologics Announces FDA Approves ASCENIV,2019-04-01 20:23:00-04:00,ADMA,positive
26858.0,ADMA Shares Halted Ahead Of Apr. 2 PDUFA Date For RI-002,2019-04-01 16:51:00-04:00,ADMA,positive
26859.0,ADMA Biologics Shares Halted News Pending,2019-04-01 16:00:00-04:00,ADMA,positive
26860.0,62 Biggest Movers From Friday,2019-04-01 04:46:00-04:00,ADMA,neutral
26861.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs",2019-03-30 09:32:00-04:00,ADMA,neutral
26862.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2019-03-29 12:45:00-04:00,ADMA,neutral
26863.0,31 Stocks Moving In Wednesday's Pre-Market Session,2019-03-27 08:39:00-04:00,ADMA,neutral
26864.0,60 Biggest Movers From Yesterday,2019-03-22 05:36:00-04:00,ADMA,neutral
26865.0,31 Stocks Moving In Thursday's Pre-Market Session,2019-03-21 07:50:00-04:00,ADMA,neutral
26866.0,30 Stocks Moving In Wednesday's Pre-Market Session,2019-03-20 07:38:00-04:00,ADMA,neutral
26867.0,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering",2019-03-14 07:47:00-04:00,ADMA,neutral
26868.0,58 Biggest Movers From Yesterday,2019-02-13 04:43:00-05:00,ADMA,neutral
26869.0,44 Stocks Moving In Tuesday's Mid-Day Session,2019-02-12 12:18:00-05:00,ADMA,neutral
26870.0,26 Stocks Moving In Tuesday's Pre-Market Session,2019-02-12 08:25:00-05:00,ADMA,neutral
26871.0,ADMA Biologics Reports Entered Into $72.5M Loan Facility With Perceptive Advisors,2019-02-12 07:39:00-05:00,ADMA,neutral
26872.0,"H.C. Wainwright Assumes ADMA Biologics at Buy, Announces Price Target $10",2019-02-07 08:22:00-05:00,ADMA,neutral
26873.0,24 Stocks Moving In Tuesday's Pre-Market Session,2019-01-08 08:19:00-05:00,ADMA,neutral
26874.0,ADMA Biologics Submits Response and Provides Supplemental Information to FDA for BIVIGAM CRL,2019-01-07 07:23:00-05:00,ADMA,neutral
26875.0,60 Biggest Movers From Yesterday,2018-12-21 05:11:00-05:00,ADMA,neutral
26876.0,Mid-Afternoon Market Update: Dow Tumbles 400 Points; DBV Technologies Shares Plummet,2018-12-20 14:47:00-05:00,ADMA,positive
26877.0,46 Stocks Moving In Thursday's Mid-Day Session,2018-12-20 12:37:00-05:00,ADMA,neutral
26878.0,Mid-Day Market Update: Crude Oil Down Over 3%; Agenus Shares Spike Higher,2018-12-20 12:13:00-05:00,ADMA,negative
26879.0,ADMA Biologics shares are trading down 46.6% after the FDA issued a CRL for its application seeking approval to relaunch BIVIGAM.,2018-12-20 10:26:00-05:00,ADMA,positive
26880.0,Mid-Morning Market Update: Markets Mostly Lower; Walgreens Earnings Top Expectations,2018-12-20 10:15:00-05:00,ADMA,negative
26881.0,ADMA Biologics Receives Complete Response Letter From FDA For BIVIGAM Approval Supplement Submission,2018-12-19 18:00:00-05:00,ADMA,positive
26882.0,ADMA Biologics Announces It Has Not Received Any Formal Written Communication From FDA Regarding BIVIGAM's Prior Approval Supplement Under The Prescription Drug Fee Act,2018-12-19 09:19:00-05:00,ADMA,positive
26883.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,ADMA,positive
26884.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2018-12-16 14:18:00-05:00,ADMA,neutral
26885.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2018-11-30 13:09:00-05:00,ADMA,neutral
26886.0,"ADMA Biologics Inc - Common Stock Q3 EPS $(0.33) Misses $(0.31) Estimate, Sales $4.23M Miss $4.69M Estimate",2018-11-08 17:06:00-05:00,ADMA,negative
26887.0,"Benzinga's Top Upgrades, Downgrades For October 30, 2018",2018-10-30 09:22:00-04:00,ADMA,positive
26888.0,"H.C. Wainwright Initiates Coverage On ADMA Biologics with Buy Rating, Announces $17 Price Target",2018-10-30 07:19:00-04:00,ADMA,neutral
26889.0,ADMA Biologics Reports FDA Established April 2 PDUFA Date For RI-002,2018-10-17 07:09:00-04:00,ADMA,neutral
26890.0,"UPDATE: ADMA Says FDA Established PDUFA Date Of Dec. 18, 2018",2018-10-11 08:51:00-04:00,ADMA,neutral
26891.0,ADMA Biologics Reports Received Formal Communication From FDA Stating Administration Considers Co.'s Recent Response Related To Prior Approval Suppplement Submission A Major Amendment; FDA Informs Co. It Requires Added 2 Months To Complete Review,2018-10-11 08:50:00-04:00,ADMA,positive
26892.0,25 Stocks Moving In Wednesday's Pre-Market Session,2018-10-03 08:10:00-04:00,ADMA,neutral
26893.0,A Peek Into The Markets: US Stock Futures Up Ahead Of ADP Report,2018-10-03 07:36:00-04:00,ADMA,neutral
26894.0,ADMA BioCenters Receives FDA Approval For Third Plasma Collection Center,2018-10-03 07:09:00-04:00,ADMA,positive
26895.0,ADMA Biologics Resubmits Biologics License Application for RI-002,2018-10-01 07:11:00-04:00,ADMA,neutral
26896.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2018-09-26 16:41:00-04:00,ADMA,neutral
26897.0,"Stocks That Made New 52-Week Highs Yesterday, September 6th",2018-09-07 16:47:00-04:00,ADMA,neutral
26898.0,"Stocks Which Set New 52-Week High Yesterday, September 5th",2018-09-06 08:48:00-04:00,ADMA,neutral
26899.0,"ADMA Biologics Reports FDA Compliance Status for its Manufacturing Facility has Improved To VAI Status, RI-002's Biologics License Application Resubmission Targeted For Q3 2018",2018-09-05 07:12:00-04:00,ADMA,positive
26900.0,"ADMA Biologics Inc - Common Stock Q2 EPS $(0.35) Misses $(0.31) Estimate, Sales $4.657M Miss $5.5M Estimate",2018-08-10 07:16:00-04:00,ADMA,negative
26901.0,"Stocks Which Set New 52-Week High Yesterday, July 30th",2018-07-31 09:20:00-04:00,ADMA,neutral
26902.0,"Benzinga's Top Upgrades, Downgrades For July 30, 2018",2018-07-30 09:09:00-04:00,ADMA,positive
26903.0,"Chardan Capital Initiates Coverage On ADMA Biologics with Buy Rating, Announces $10 Price Target",2018-07-30 06:14:00-04:00,ADMA,neutral
26904.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,ADMA,neutral
26905.0,"Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter",2018-07-27 08:44:00-04:00,ADMA,neutral
26906.0,60 Biggest Movers From Yesterday,2018-07-27 04:06:00-04:00,ADMA,neutral
26907.0,"Maxim Group Maintains Buy On ADMA Biologics, Raises Price Target To $12",2018-07-26 14:20:00-04:00,ADMA,neutral
26908.0,"ADMA Shares Spike 1.9%, Volume Spiking After Hearing Maxim Raised Price Target From $10 To New Street High Of $12",2018-07-26 14:12:00-04:00,ADMA,positive
26909.0,40 Stocks Moving In Thursday's Mid-Day Session,2018-07-26 12:02:00-04:00,ADMA,neutral
26910.0,ADMA Biologics Reports Successful Close-Out Of April FDA Compliance Inspection,2018-07-26 10:51:00-04:00,ADMA,positive
26911.0,"ADMA Biologics Shares Resume Trade, Pullback From Session High, Still Up 18.5% For Session But Down 6.7% From High",2018-07-26 10:02:00-04:00,ADMA,positive
26912.0,ADMA Biologics Halted Up 24.9% At $6.17/Share,2018-07-26 09:56:00-04:00,ADMA,neutral
26913.0,ADMA Biologics Receives October 25 PDUFA Date For BIVIGAM Regulatory Submission,2018-07-26 08:52:00-04:00,ADMA,neutral
26914.0,UPDATE: ADMA Says Amendment Provides For Reimbursement Of ADMA BioManufacturing For Difference In Price Co. Incurs,2018-07-24 17:08:00-04:00,ADMA,neutral
26915.0,"ADMA Biologics 8-K Shows Co., Biotest Pharma Entered Amendment For Plasma Supply Deal: 'provides for the sale by BPC to ADMA BioManufacturing of hyperimmune plasma containing antibodies to the hepatitis B virus'",2018-07-24 17:07:00-04:00,ADMA,neutral
26916.0,30 Stocks Moving In Friday's Mid-Day Session,2018-07-13 12:38:00-04:00,ADMA,neutral
26917.0,"Oppenheimer Initiates Coverage On ADMA Biologics with Outperform Rating, Announces $13 Price Target",2018-07-13 09:47:00-04:00,ADMA,neutral
26918.0,"ADMA Biologics Shares Unaffected After Hours; Oppenheimer Initiated Outperform Rating, $13 Price Target",2018-07-12 16:09:00-04:00,ADMA,positive
26919.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,ADMA,negative
26920.0,ADMA Biologics Prices 8.36M Share Offering At $1.78/Share For Gross Proceeds Of $40M,2018-06-08 09:08:00-04:00,ADMA,negative
26921.0,"ADMA Biologics Reports Offering Of Common Stock, No Terms Disclosed",2018-06-07 16:05:00-04:00,ADMA,negative
26922.0,"ADMA Biologics Granted U.S. Patent for Treating Respiratory Infections, Fourth Patent Issued to the Company in the U.S. Provides Coverage for RI-002 Through 2035",2018-05-16 07:30:00-04:00,ADMA,positive
26923.0,"ADMA Biologics Q1 EPS $(0.39) Misses $(0.28) Estimate, Sales $4M Miss $6.19M Estimate",2018-05-14 17:05:00-04:00,ADMA,negative
26924.0,"ADMA Bilogics Resumes Trade, Now Up 2.2% At $5.10/Share",2018-05-14 13:45:00-04:00,ADMA,neutral
26925.0,ADMA Biologics Shares To Resume Trade At 1:45 p.m. EDT,2018-05-14 13:40:00-04:00,ADMA,positive
26926.0,"ADMA Biologics Retires Approximately 8.6M Shares Previously Issued to Biotest, Capital Structure Improved as Total Outstanding Common Stock Reduced By Approximately 19%",2018-05-14 13:18:00-04:00,ADMA,positive
26927.0,ADMA Biologics Halted News Pending,2018-05-14 13:02:00-04:00,ADMA,neutral
26928.0,"ADMA Biologics Highlights Successful Completion Of Manufacturing, Release, Commercial Sales Of First Batch Of Nabi-HB",2018-04-24 07:28:00-04:00,ADMA,positive
26929.0,"Benzinga Pro's Top 10 Most-Searched Tickers On Tues., Mar. 6",2018-03-06 12:59:00-05:00,ADMA,positive
26930.0,"ADMA Biologics Reports FY17 EPS $(1.91) vs $(1.86) Est., Sales $22.76M vs $17.46M Est.",2018-03-05 07:06:00-05:00,ADMA,neutral
26931.0,A Day Trader's Guide To Market Psychology,2018-02-15 15:54:00-05:00,ADMA,neutral
26932.0,32 Stocks Moving In Monday's Mid-Day Session,2018-02-12 12:20:00-05:00,ADMA,neutral
26933.0,"ADMA Biologics Shares Recently Turned Positive, Now Up 9% For Session; Hearing Chatroom Chatter Co. Mentioned Positively Via A Newsletter",2017-12-26 13:45:00-05:00,ADMA,positive
26934.0,ADMA Biologics Reports Filing Of BLA For Third Plasma Collection Center,2017-12-11 07:09:00-05:00,ADMA,neutral
26935.0,"ADMA Biologics Reports US PTO Issued Co. Patent No. 9,815,886 Related To Compositions, Methods For Treatment Of Immundeficiency",2017-11-15 08:10:00-05:00,ADMA,negative
26936.0,46 Biggest Movers From Yesterday,2017-11-15 05:04:00-05:00,ADMA,neutral
26937.0,42 Stocks Moving In Tuesday's Mid-Day Session,2017-11-14 12:25:00-05:00,ADMA,neutral
26938.0,"Benzinga's Top Upgrades, Downgrades For November 14, 2017",2017-11-14 09:13:00-05:00,ADMA,positive
26939.0,34 Stocks Moving In Tuesday's Pre-Market Session,2017-11-14 08:06:00-05:00,ADMA,neutral
26940.0,Raymond James Upgrades ADMA Biologics to Outperform,2017-11-14 07:19:00-05:00,ADMA,neutral
26941.0,"Adma Biologics 10%+ Owner Biotest Pharmaceuticals Buys 5,813,954 @ Avg Price: $2.15 -Form4",2017-11-13 13:56:00-05:00,ADMA,neutral
26942.0,"Adma Biologics CEO Grossman  Buys 485,000 @ Avg Price: $2.15 -Form4",2017-11-13 13:54:00-05:00,ADMA,neutral
26943.0,ADMA Biologics Announces Pricing of Follow-On Offering Of 17M Shares At $2.15/Share,2017-11-09 08:58:00-05:00,ADMA,positive
26944.0,"ADMA Biologics Reports Q3 EPS $(0.59) vs $(0.42) Est., Sales $4.729M vs $6.46M Est.",2017-11-03 17:03:00-04:00,ADMA,neutral
26945.0,ADMA Biologics Reports Q2 EPS $(0.55) vs $(0.26) Est.,2017-08-11 16:16:00-04:00,ADMA,neutral
26946.0,ADMA Biologics Reports Newly Issued US Patent For Immunotherapeutic Methods,2017-07-31 16:16:00-04:00,ADMA,neutral
26947.0,ADAM Biologics CEO Sends Letter to Stakeholders,2017-06-27 07:20:00-04:00,ADMA,neutral
26948.0,Biotest AG Reports 25% Stake In ADMA Biologics,2017-06-16 14:51:00-04:00,ADMA,neutral
26949.0,"ADMA Biologics Reports Q1 EPS $(0.51) vs $(0.28) Est., Sales $2.629M vs $2.97M Est.",2017-05-12 16:13:00-04:00,ADMA,neutral
26950.0,ADMA Biologics to Acquire Assets From Biotest Pharma for $40M Cash,2017-01-23 07:01:00-05:00,ADMA,positive
26951.0,"ADMA Biologics Reports Q3 Loss/Share $0.34 vs Est Loss/Share $0.42, Rev $2.938M vs $2.39M Est",2016-11-10 16:31:00-05:00,ADMA,neutral
26952.0,22 Stocks With Three-Day Increasing Volume,2016-09-21 09:16:00-04:00,ADMA,neutral
26953.0,7 Stocks Which Rallied Three Days On Increasing Volume,2016-09-21 08:54:00-04:00,ADMA,neutral
26954.0,ADMA Biologics Reports Q2 EPS $(0.50) vs. Prior Year Quarter $(0.44),2016-08-12 16:39:00-04:00,ADMA,neutral
26955.0,10 Biggest Mid-Day Losers For Monday,2016-08-01 13:02:00-04:00,ADMA,negative
26956.0,Mid-Day Market Update: Crude Oil Down 3%; FleetMatics Group Shares Rise Following Acquisition News,2016-08-01 12:18:00-04:00,ADMA,negative
26957.0,Mid-Morning Market Update: Markets Mostly Higher; Tesla To Acquire SolarCity,2016-08-01 10:19:00-04:00,ADMA,neutral
26958.0,Benzinga's Top Downgrades,2016-08-01 09:17:00-04:00,ADMA,positive
26959.0,15 Stocks Moving In Monday's Pre-Market Session,2016-08-01 08:34:00-04:00,ADMA,neutral
26960.0,ADMA Biologics Downgraded At Maxim From Buy To Hold,2016-08-01 07:11:00-04:00,ADMA,neutral
26961.0,ADMA Biologics Downgraded At Raymond James From Strong Buy To Market Perform,2016-08-01 07:10:00-04:00,ADMA,positive
26962.0,ADMA Biologics Receives CRL from FDA for Pending Biologics License Application,2016-07-31 08:14:00-04:00,ADMA,neutral
26963.0,ADMA Biologics Prices 1.892M Shares Offering At $6.50/Share,2016-04-28 09:16:00-04:00,ADMA,positive
26964.0,ADMA Biologics Reports Proposed Public Offering of Common Stock,2016-04-27 17:06:00-04:00,ADMA,neutral
26965.0,"UPDATE: Shares of ADMA Biologics Halted on Circuit Breaker, Now Up ~11% to $6.70",2016-02-01 10:28:00-05:00,ADMA,positive
26966.0,ADMA Biologics Halted On Volatility,2016-02-01 10:28:00-05:00,ADMA,neutral
26967.0,"ADMA Biologics Reports Q3 EPS $(0.48) vs. Est. $(0.39), Rev. $1.852M vs. Est. $1.5M",2015-11-10 16:53:00-05:00,ADMA,neutral
26968.0,ADMA Biologics Gets Milestone Payment From Biotest AG for RI-002 BLA Submission to FDA,2015-09-30 07:28:00-04:00,ADMA,neutral
26969.0,ADMA Biologics Announces FDA Acceptance of License App for RI-002,2015-09-21 07:28:00-04:00,ADMA,positive
26970.0,ADMA Biologics Receives FDA Approval for Second Plasma Collection Center,2015-09-17 07:38:00-04:00,ADMA,positive
26971.0,ADMA Biologics Gets Patent Issuance Pertaining to the Treatment of Immunodeficiency,2015-08-31 16:35:00-04:00,ADMA,neutral
26972.0,"ADMA Biologics Reports Q2 EPS $(0.44) vs. Est. $(0.36), Rev. $1.291M vs. Est. $1.53M",2015-08-11 16:38:00-04:00,ADMA,neutral
26973.0,ADMA Biologics Receives Notice of Allowance for U.S. Patent Regarding Its Lead Product Candidate RI-002,2015-06-30 07:10:00-04:00,ADMA,neutral
26974.0,"ADMA Biologics, Jeffrey Modell Foundation Begin Strategic Patient Advocacy Alliance",2015-06-11 07:42:00-04:00,ADMA,neutral
26975.0,"ADMA Biologics Reports Q1 EPS $(0.37) vs. Est. $(0.38), Rev. $1.503M vs. Est. $1.5M",2015-05-12 16:45:00-04:00,ADMA,neutral
26976.0,"Adma Biologics Holder Broadfin Reports 9.2% Stake, Up From 3.7% On Dec 21 2014",2015-03-19 12:45:00-04:00,ADMA,neutral
26977.0,ADMA Biologics Prices 1.225M Shares at $8/Share for Gross Proceeds ~$9.8M,2015-03-13 09:24:00-04:00,ADMA,negative
26978.0,ADMA Biologics Announces Offering of Shares,2015-03-12 16:33:00-04:00,ADMA,positive
26979.0,Morning Market Gainers,2015-02-23 09:44:00-05:00,ADMA,neutral
26980.0,"Monday's #PreMarket Movers: Spectrum Pharmaceuticals, Cyberark Software Trending Down",2015-02-23 08:57:00-05:00,ADMA,neutral
26981.0,"ADMA Biologics Reports Positive Data from Phase III RI-002 Trial, Showed Primary, Secondary Endpoints",2015-02-23 07:40:00-05:00,ADMA,positive
26982.0,ADMA Biologics Receives $5M Tranche From Hercules Technology Growth Capital,2014-12-15 08:13:00-05:00,ADMA,positive
26983.0,ADMA Biologics Shares Halted to Announce Phase 3 Study of RI-002 Achieved Primary Endpoint,2014-12-03 08:09:00-05:00,ADMA,positive
